BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xie Y, Tian Y, Zhang Y, Zhang Z, Chen R, Li M, Tang J, Bian J, Li Z, Xu X. Overview of the development of selective androgen receptor modulators (SARMs) as pharmacological treatment for osteoporosis (1998–2021). European Journal of Medicinal Chemistry 2022;230:114119. [DOI: 10.1016/j.ejmech.2022.114119] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Kargbo RB. Targeted Degradation of Androgen Receptor for the Potential Treatment of Prostate Cancer. ACS Med Chem Lett . [DOI: 10.1021/acsmedchemlett.2c00415] [Reference Citation Analysis]
2 Avgeris I, Pliatsika D, Nikolaropoulos SS, Fousteris MA. Targeting androgen receptor for prostate cancer therapy: From small molecules to PROTACs. Bioorg Chem 2022;128:106089. [PMID: 35973305 DOI: 10.1016/j.bioorg.2022.106089] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]